Seeking Alpha

Onyx Pharmaceuticals (ONXX) announces a 4.4M share secondary offering with a 30-day option to...

Onyx Pharmaceuticals (ONXX) announces a 4.4M share secondary offering with a 30-day option to purchase up to an additional 660K shares to cover over-allotments, if any. The offering is expected to close by January 22, 2013, and the company intends to use the net proceeds to fund its clinical development programs, R&D, and sales and marketing activities to globally commercialize Kyprolis. BofA Merrill Lynch and Barclays are co-book runners. Shares -2% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector